RxDoctor Payments Data

Rachel Bernard, PA

Medical · Ridley Park, PANPI 1578335469

Payments from drug & device makers

$3,991in general payments, 2019–2025

Across 207 payments — averaging $19.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$508
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$503
  • Novo Nordisk$391
  • Kowa Pharmaceuticals America, Inc.$295
  • Amgen$232
  • AstraZeneca$226
  • plus $2K from 26 others

What the payments were for

  • Food & beverage$3,991100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,991 in reported general payments places this provider in the 85th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$26,676
Medicare patients
154
Services billed
324

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide11$10,142
Albuterol Sulfate HfaAlbuterol Sulfate31$566
Atorvastatin Calcium32$413
Levothyroxine Sodium18$342
Losartan Potassium22$267
Rosuvastatin Calcium22$218
Amlodipine Besylate33$213
Montelukast Sodium20$179
Metformin Hcl17$178
Sertraline Hcl19$168
Omeprazole15$159
Pantoprazole Sodium12$158
Lisinopril31$146
Doxycycline Hyclate24$139
Fluticasone Propionate14$131

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$391$10,14211 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$16$34218 claims
Almatica Pharma LLCSertraline Hcl$70$16819 claims
PfizerPaxlovid$214$012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Ridley Park

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →